Skip to main content
RMTI
NASDAQ Life Sciences

Rockwell Medical Reports Strong Preliminary Q4 & Full-Year 2025 Results with Positive Cash Flow and Improved Cash Position

Analysis by Wiseek AI
Sentiment info
Positive
Importance info
8
Price
$1.08
Mkt Cap
$37.723M
52W Low
$0.78
52W High
$2.265
Market data snapshot near publication time

Summary

Rockwell Medical announced strong preliminary unaudited financial results for Q4 and full-year 2025, highlighting significant revenue growth, improved gross margins, and positive cash flow from operations, leading to a strengthened cash position.


Key Events

  • Preliminary Q4 & Full-Year 2025 Financials

    Rockwell Medical reported preliminary unaudited net sales of approximately $18.6 million for Q4 2025 and $69.5 million for the full-year 2025.

  • Improved Profitability Metrics

    The company expects Q4 2025 gross margin to be approximately 22%, a notable increase from 14% in Q3 2025, reflecting improved operational efficiencies and reduced expenses.

  • Positive Cash Flow from Operations

    Rockwell Medical anticipates reporting approximately $2.3 million in cash flow from operations for Q4 2025, marking its second cash flow positive quarter in 2025.

  • Strengthened Cash Position

    Cash and cash equivalents and investments available-for-sale are expected to increase to approximately $25 million as of December 31, 2025.


Analysis

Rockwell Medical's preliminary unaudited financial results indicate a significant positive shift in its financial health and operational efficiency. For a company of this size, achieving positive cash flow from operations for the second quarter in 2025 and substantially increasing its cash reserves to $25 million are critical milestones. The notable improvement in gross margin from 14% to 22% in Q4 also highlights successful cost reduction and operational improvements. These results suggest the company is making progress towards sustainable profitability and has significantly extended its financial runway, which is a major de-risking event for a micro-cap company.

At the time of this filing, RMTI was trading at $1.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.7M. The 52-week trading range was $0.78 to $2.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RMTI - Latest Insights

RMTI
May 08, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8338
Real-time Price: $0.6248 info
Change: -$0.209 (-25%) info
Market Cap: $24.661M info
RMTI
May 07, 2026, 6:59 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.830
Real-time Price: $0.6248 info
Change: -$0.2052 (-25%) info
Market Cap: $24.661M info
RMTI
May 07, 2026, 6:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.807
Real-time Price: $0.6248 info
Change: -$0.1822 (-23%) info
Market Cap: $24.661M info
RMTI
May 07, 2026, 6:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.807
Real-time Price: $0.6248 info
Change: -$0.1822 (-23%) info
Market Cap: $24.661M info
RMTI
Apr 30, 2026, 6:59 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.918
Real-time Price: $0.6248 info
Change: -$0.2932 (-32%) info
Market Cap: $24.661M info
RMTI
Apr 20, 2026, 4:09 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.9387
Real-time Price: $0.6248 info
Change: -$0.3139 (-33%) info
Market Cap: $24.661M info
RMTI
Mar 26, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.918
Real-time Price: $0.6248 info
Change: -$0.2932 (-32%) info
Market Cap: $24.661M info
RMTI
Mar 26, 2026, 7:01 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.6248 info
Change: -$0.3452 (-36%) info
Market Cap: $24.661M info
RMTI
Mar 26, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.797
Real-time Price: $0.6248 info
Change: -$0.1722 (-22%) info
Market Cap: $24.661M info
RMTI
Jan 20, 2026, 6:32 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $0.6248 info
Change: -$0.4552 (-42%) info
Market Cap: $24.661M info